Case Study: Using Health Care Spending Guiding Principles to Evaluate "Will Reducing Drug Prices Slow Innovation" Read more about Case Study: Using Health Care Spending Guiding Principles to Evaluate "Will Reducing Drug Prices Slow Innovation"
New Moves to Shine More Light Into an Opaque Drug Pricing System Read more about New Moves to Shine More Light Into an Opaque Drug Pricing System
Drug Price Regulation Trade-offs: Real or Imagined? Read more about Drug Price Regulation Trade-offs: Real or Imagined?
Drug Price Controls in Medicare Part D: Not a Remedy for More Than 5 Million Medicare Beneficiaries Read more about Drug Price Controls in Medicare Part D: Not a Remedy for More Than 5 Million Medicare Beneficiaries
Patient-Centered Guiding Principles for Reforming Health Care to Address Rising Health Care Spending Read more about Patient-Centered Guiding Principles for Reforming Health Care to Address Rising Health Care Spending
Patient-Centered Guiding Principles for Evaluating Health Care Spending Read more about Patient-Centered Guiding Principles for Evaluating Health Care Spending
NPC in Chain Drug Review: Fostering a More Informed Drug Pricing Conversation Read more about NPC in Chain Drug Review: Fostering a More Informed Drug Pricing Conversation
NPC in RealClearPolicy: Price Setting Bill Is No Panacea for Patients Read more about NPC in RealClearPolicy: Price Setting Bill Is No Panacea for Patients
Digging Deeper Into Health Spending | November 2021 Read more about Digging Deeper Into Health Spending | November 2021